FINAL PROGRAMME

(updated 1970-01-01)

Thursday, February 12

10.00–13.00

11.30–13.00

12.00

 

Registration, mounting of posters, delivery of files for presentations.

Lunch

Opening of exhibition

 

13.00-13.10

13.10–15.00

13.10-13.55
 

13.55-14.15

14.15-15.00
 

Welcome and Practical Information (Ingvar Eliasson)

Lyme Borreliosis. (Chairperson: Dag Nyman)

Lyme disease, epidemiology and diagnosis, a European perspective (Gerold Stanek)

Epidemiology in Scandinavia. (Katharina Ornstein)

The rôle of Borrelia burgdorferi surface antigens in the pathogenesis of borrelia infection. (Sven Bergström)

 

15.00–16.00

Coffee and Exhibition

 

16.00–18.00

16.00-16.15

16.15-16.45
 

16.45-17.05
 

17.05-17.25
 

17.25-17.45
 

17.45–18.00

Diagnosis of Lyme borreliosis. (Chairperson: Ram Dessau)

Survey of laboratory methods in use in Scandinavia. (Ram Dessau)

The pathogenesis of Lyme neuroborreliosis. The use of CXCL13 and other markers in diagnosis. (Tobias Rupprecht)

Chemokine CXCL13 in Cerebrospinal Fluid as Marker of Disease Activity in Neuroborreliosis. (Dag Nyman)

PCR – current experiences from a clinical laboratory. (Katharina Ornstein, Ann-Cathrine Petersson)

MHC Dextramers for detection of Borrelia-specific T-cells using flow cytometry. (Liselotte Brix)

Questions & Discussion

 

18.00–19.00

19.00–

Unscheduled time

Dinner, followed by Poster Pub & Exhibition

Friday, February 13

08.00–09.40

08.00–08.20
 

08.20–08.40

08.40–08.50
 

08.50–09.00
 
 

09:00–09:20

Diagnosis of Lyme borreliosis. (Chairperson: Ingvar Eliasson)

Early cytokine expression in skin from patients with different outcome of Borrelia burgdorferi infection. (Christina Ekerfeldt)

Neuroborreliosis and intrathecal antibodies. (Tone Skarpaas)

Validation of 7 different ELISA-kits for Borrelia without having access to a serum panel from patients with known clinical diagnosis. (Eva Hjelm)

Borrelia-specific immune complexes in lyme borreliosis, a marker of persisting disease and a tool in evaluation of therapeutic effect?
( Per H. Bjark)

Which test for diagnostic serology in Lyme Borreliosis: ELISA(s) and/or immunoblot. (Dag Nyman)

09.20–10.00

Coffee and Exhibition

 

10.00–11.25

Theme: Statistical evaluation of diagnostic tests for classification and prediction.

Going beyond ROC curves – Risk prediction instead of positive/negative. Regression methods for paired samples. (Jørgen Hilden)

Analysing and evaluating quantitative results for serological diagnosis of Lyme borreliosis. How to increase the diagnostic value.
(Ram Dessau)

11.30–12.30

11.30–11.45
 

11.45–12.00
 

12.00–12.15
 
 

12.15–12.30

Serodiagnosis of Lyme borreliosis. (Chairperson: Tone Skarpaas)

Experiences from the national quality assurance programme EQUALIS. (Torbjörn Kjerstadius)

Evaluation of four different serological tests for Borrlia burgdorferi sensu lato. (Jan Egil Afset)

Anti-borrelia antibody prevalence in a group of high risk forest workers in Poland measured with a novel recombinant plus native borrelia antigen line blot. (Victor Herbst, Patryk Matusek)

Application of recombinant Borrelial antigens for the development of a new Line assay and a Luminex based high through put confirmation test. (Hubert Ammer)

12.30–13.30

Lunch

 

13.30–14.30

Panel discussion on diagnostic strategies
(Chairperson: Ingvar Eliasson)

Closure of the meeting

 

14.30

Coffee and departure